Sign in
BIO Stock Price, Chart, Stats & News
Bio-Rad Laboratories, Inc.
Save
Bio-Rad Laboratories, Inc. (BIO) does not currently pay a dividend.
9.92B
Market cap
39.71x
Current P/E
40.32x
Forward P/E
BIO chart
Fundamentals
Gross margin | 51.87% |
Operating margin | 8.87% |
Pretax margin | 38.54% |
Net margin | 29.42% |
Effective tax rate | 23.67% |
ROA | 7.18% |
ROE | 10.86% |
D/E | 0.21x |
Interest coverage ratio | 4.68x |
BIO valuation
P/E | 39.71x |
P/S | 2.77x |
P/B | 0.96x |
P/CF | 13.45x |
P/FCF | 19.12x |
P/OCF | 13.45x |
PEG | 0.04x |
EV multiple | 7.29x |
About
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics.
Similar securities
Based on sector and market capitalization
Report issue